Overview A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers Status: Completed Trial end date: 2009-04-01 Target enrollment: Participant gender: Summary This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure. Phase: Phase 1 Details Lead Sponsor: Peplin